{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:40:07Z","timestamp":1750542007681,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 52-year-old woman previously treated for a stage IIIc high-grade ovarian serous carcinoma presented right upper quadrant abdominal pain, 3 years after extended surgery and chemotherapy. Abdominal CT, MRI, and <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed a right hepatic mass, consistent for lone recurrence nearby the hepatic lateral fissure. Preoperative and histologic examination identified a peritoneal lateral fissure lesion. The patient underwent atypic segment 5 segmentectomy. She has been disease-free for 3 years now. Advanced ovarian cancer can be responsible for perihepatic sulcus lesions, such as this right fissure lesion. They should not be mistaken for inoperable parenchyma metastases.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003675","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T03:01:54Z","timestamp":1620010914000},"page":"e424-e427","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Lateral Hepatic Fissure Peritoneal Carcinomatosis as a Pitfall for Hepatic Metastasis of Advanced Ovarian Cancer"],"prefix":"10.1097","volume":"46","author":[{"given":"Erwan","family":"Gabiache","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Institut Claudius Regaud\u2013Institut Universitaire du Cancer de Toulouse\u2013Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Chantalat","sequence":"additional","affiliation":[{"name":"Gynecology Department, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slimane","family":"Zerdoud","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Institut Claudius Regaud\u2013Institut Universitaire du Cancer de Toulouse\u2013Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gw\u00e9na\u00ebl","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2214\/ajr.179.2.1790391","article-title":"Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer","volume":"179","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00259-015-3184-5","article-title":"Predictive value of (18)F-FDG PET\/CT in restaging patients affected by ovarian carcinoma: a multicentre study","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00259-017-3638-z","article-title":"An update on the role of PET\/CT and PET\/MRI in ovarian cancer","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/annonc\/mdw663","article-title":"Fifth ovarian cancer consensus conference of the gynecologic cancer intergroup: recurrent disease","volume":"28","year":"2017","journal-title":"Ann Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.2016152595","article-title":"Patterns and prognostic importance of hepatic involvement in patients with serous ovarian cancer: a single-institution experience with 244 patients","volume":"282","year":"2017","journal-title":"Radiology"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian carcinomatosis, how the radiologist can help plan the surgical approach","volume":"32","year":"2012","journal-title":"Radiographics"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:03Z","timestamp":1750539783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003675","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}